8-K
filed May 21, 2026, 4:01 PM ET
ticker CTRE
CIK 0001590717
other material
confidence high
sentiment neutral
materiality 0.50
CareTrust REIT closes full exercise of underwriters' option for additional 1.875M shares at $40.225/sh
CareTrust REIT, Inc.
- Underwriters exercised option in full for additional 1,875,000 shares at $40.225 per share.
- Total offering includes 12,500,000 firm shares plus 1,875,000 optional shares; closed May 21, 2026.
- Company entered additional forward sale agreements with Wells Fargo and JPMorgan for the optional shares.
- Forward purchasers borrowed and sold the optional shares on May 21, 2026.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001140361-26-022438
- form_type
- 8-K
- ticker
- CTRE
- cik
- 0001590717
- company_name
- CareTrust REIT, Inc.
- filed_at
- 2026-05-21T20:01:38+00:00
- discovered_at
- 2026-05-21T20:03:00.332617+00:00
- generated_at
- 2026-05-21T20:04:59.424471+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001140361-26-022438
- json_url
- https://secwatch.observer/filing/0001140361-26-022438.json
- markdown_url
- https://secwatch.observer/filing/0001140361-26-022438.md
- text_url
- https://secwatch.observer/filing/0001140361-26-022438.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1590717/000114036126022438/0001140361-26-022438-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1590717/000114036126022438/ef20074571_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
EMYB
Embassy Bancorp expands stock repurchase program by additional $5M
Embassy Bancorp, Inc.
June 1, 2026, 4:37 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CTXR
Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned
Citius Pharmaceuticals, Inc.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CTOR
Citius Oncology reports Phase 1 combo data for LYMPHIR in gynecologic cancers; 24% ORR, 33% in endometrial cancer
CITIUS ONCOLOGY, INC.
June 1, 2026, 4:30 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SYRE
Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030
Spyre Therapeutics, Inc.
June 1, 2026, 4:01 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ORKA
Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030
Oruka Therapeutics, Inc.
June 1, 2026, 4:01 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
VIASP
Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends
Via Renewables, Inc.
June 1, 2026, 3:06 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
BUKS
CEO Christopher Reedy discloses ongoing cancer treatment; remains in role
BUTLER NATIONAL CORP
June 1, 2026, 12:41 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CPSH
CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share
CPS TECHNOLOGIES CORP/DE/
June 1, 2026, 9:35 AM ET
other_material
Items 1.01, 5.03, 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.